PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
ERK1 18,374 Target Target ERK2 3,287 1,788 0.23 -0.64 0.54 0.82
Eotaxin-3/CCL26 26 Target Target Eotaxin-2/CCL24 19 10 0.45 -0.54 0.53 0.94
CCL19 658 Target Target CCL21 808 344 0.47 -0.52 0.52 0.93
Epigen 27 Target Target EGF 27,487 14 0.02 -0.69 0.52 0.67
ANGPT1 81 Target Target ANGPT2 105 42 0.46 -0.54 0.52 0.94
CD4 112,219 Target Target Ck-beta-11 4 2 0.00 -0.71 0.50 0.61
ADRBK2 8 Target Target Beta-Adrenergic Receptor Kinase 2 15 4 0.37 -0.61 0.50 0.93
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
EPHB3 118 Target Target EPHB2 385 59 0.28 -0.65 0.50 0.88
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
Erbb2 4,536 Target Target ERBB4 994 461 0.22 -0.69 0.46 0.83
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72